Press release
Erythropoietin Market Gains Momentum Amid Rising Incidence Of Chronic Kidney Diseases: A Key Factor Shaping the Future of the Erythropoietin (EPO) Market in 2025
Erythropoietin (EPO) Market Size
The value of the erythropoietin (EPO) market has seen a swift growth in the past few years. The market which is valued at $17.29 billion in 2024 is projected to touch $19.25 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.4%. Factors such as increasing patient awareness and education, consolidation in the pharmaceutical industry, changes in healthcare reimbursement policies, expanding market size and demand, expiration of patents and the introduction of biosimilars attributed to its growth in the historic period.
The market size for erythropoietin (EPO) is predicted to expand dramatically in the upcoming years, reaching a valuation of $30.92 billion in 2029 with a compound annual growth rate (CAGR) of 12.6%. Factors contributing to this growth during the forecast period includes factors like market competition, impact of biosimilars, projected disease prevalence, changes in healthcare policy and reimbursements, the growth of emerging markets, plus a focused approach on clinical trials and research. Key trends anticipated during this period include optimization of supply chain management, global expansion into new markets, raising patient awareness and education, revising reimbursement policies, and industry consolidation and mergers.
What Are the Main Catalysts for Growth in the Erythropoietin (EPO) Market?
The erythropoietin market is predicted to see a surge in demand due to the increasing prevalence of chronic kidney diseases. Erythropoietin, which is used in the production of red blood cells and enhances immunity, is crucial for treating rising cases of chronic kidney disease. For instance, the Centers for Disease Control, a federal agency based in the US, approximated that around 14% of adults in the U.S., corresponding to nearly 35.5 million people, would suffer from chronic kidney disease (CKD) in 2023. Hence, with chronic kidney diseases becoming increasingly common, the need for erythropoietin intensifies, leading a surge in market revenues.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smp
Which Businesses Are at the Forefront of Erythropoietin (EPO) Market Development?
Major companies operating in the erythropoietin (EPO) market include Amgen Inc., Roche Holding AG, Pfizer Inc., Merck & Co., Teva Pharmaceutical Industries Ltd., 3SBio Inc., Celltrion Inc., Intas Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Reliance Life Sciences Pvt. Ltd., Biocon Limited, Chugai Pharmaceutical Co., Kyowa Kirin Co. Ltd., Apotex Inc., CJ Healthcare Corp., STADA Arzneimittel AG, Hospira Inc., Sandoz International GmbH, Torrent Pharmaceuticals Ltd., LG Life Sciences Ltd., Sanofi S.A., Bayer AG, Hikma Pharmaceuticals.
What Are the Latest Innovations in the Erythropoietin (EPO) Market?
Leading firms in the erythropoietin market are concentrating on launching oral medications as a more convenient substitute to conventional injectable therapies. These new treatments aim to enhance patient comfort, boost adherence to treatment regimens and offer greater treatment flexibility, particularly for those dealing with chronic conditions like anemia associated with chronic kidney disease (CKD). For example, in February 2023, GlaxoSmithKline (GSK), a global pharmaceutical and biotech company based in the UK, released Jesduvroq (daprodustat) tablets. This oral therapy works to elevate erythropoietin levels which then aids in managing anemia in CKD patients by maintaining hemoglobin levels within the desired range. The main goal of Jesduvroq is to act as a more convenient alternative to injectable treatments, thus improving the comfort, adherence to treatment and overall flexibility for patients undergoing dialysis.
How Is the Erythropoietin (EPO) Market Segmented?
The erythropoietin (EPO) market covered in this report is segmented -
1) By Product: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Other Products
2) By Drug Class: Biologist, Biosimilar
3) By Application: Cancer, Hematology, Renal Diseases, Neurology, Other Applications
Subsegments:
1) By Epoetin-Alfa: Epoetin-Alfa, Epoetin-Alfa Biosimilars
2) By Epoetin-Beta: Epoetin-Beta, Epoetin-Beta Biosimilars
3) By Darbepoetin-Alfa: Darbepoetin-Alfa, Darbepoetin-Alfa Biosimilars
4) By Other Products: Peginesatide, Other Novel EPO Products
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report
Where Is the Erythropoietin (EPO) Market Growth Most Prominent?
The countries covered in the erythropoietin (epo) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
What Is Covered In The Erythropoietin (EPO) Global Market Report?
- Market Size Analysis: Analyze the Erythropoietin (EPO) Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Erythropoietin (EPO) Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Erythropoietin (EPO) Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Erythropoietin (EPO) Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3436
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erythropoietin Market Gains Momentum Amid Rising Incidence Of Chronic Kidney Diseases: A Key Factor Shaping the Future of the Erythropoietin (EPO) Market in 2025 here
News-ID: 3931514 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for EPO
Erythropoietin (EPO) Treatment Market Outlook and Future Projections for 2030
The erythropoietin (epo) treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the…
Erythropoietin (EPO) Treatment Market, Global Outlook and Forecast 2025-2033
Summary: The Global Erythropoietin (EPO) Treatment Market was valued at US$9242 million in 2022 and is projected to reach US$ 19070 million by 2033, at a CAGR of 6.2% during the forecast period. The Global Erythropoietin (EPO) Treatment Market was valued at US$ 9.24 billion in 2022 and is expected to reach US$ 14.07 billion by 2029, growing at a 6.2% CAGR. EPO is primarily used to treat anemia caused…
Erythropoietin (EPO) Market Analysis & Growth Insights 2024-2033
The Business Research Company recently released a comprehensive report on the Global Erythropoietin (EPO) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
EPO Biomarkers Market Size, Share | Forecast 2032
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global EPO Biomarkers Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in…
Erythropoietin (EPO) Drugs Market: An Overview
Introduction:
Erythropoietin (EPO) is a glycoprotein hormone that plays a crucial role in regulating red blood cell production (erythropoiesis) in the body. EPO drugs are synthetic versions of this hormone used to treat anemia, particularly in patients with chronic kidney disease (CKD), cancer, HIV, and other critical conditions that impact red blood cell production. EPO drugs help maintain adequate hemoglobin levels, improving the quality of life for patients by reducing the…
Global EPO Biomarkers Market Research and Forecast 2018-2023
Global EPO biomarkers market size, market intelligence, market trends, research and analysis report by biomarker (erythropoietin alfa, beta, zeta, theta, recombinant human erythropoietin, darbepoetin alfa) by applications (end-stage renal disorder, cancers, rheumatoid arthritis, aids, myelodysplastic syndrome, neurology, hematology) forecast 2018-2023
According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications,…
